Skip Navigation LinksHome > July 2015 - Volume 37 - Issue 5 > Chemotherapy for Generalized Infantile Myofibromatosis With...
Journal of Pediatric Hematology/Oncology:
doi: 10.1097/MPH.0000000000000132
Clinical and Laboratory Observations

Chemotherapy for Generalized Infantile Myofibromatosis With Visceral Involvement

Wu, Susan Y. MSIII*; McCavit, Timothy L. MD†,‡; Cederberg, Kevin MD§; Galindo, Rene L. MD, PhD†,∥,¶; Leavey, Patrick J. MD†,‡

Collapse Box


Infantile myofibromatosis (IM) is most commonly limited to cutaneous lesions that resolve spontaneously. However, generalized IM with visceral involvement, which has a reported mortality rate as high as 73%, has been successfully treated with a combination of methotrexate and vinblastine. Here we report the further efficacy of low-dose methotrexate and vinblastine in 2 pediatric patients with IM and visceral involvement and review the literature describing chemotherapy for these patients.

Copyright © 2015 Wolters Kluwer Health, Inc. All rights reserved.


Article Tools


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.

Connect With Us


For additional oncology content, visit LWW Oncology Journals on Facebook.